Industry Slams UK Plan To ‘Demand A Third’ Of Drug Company Revenue In Q2/Q3 2025

 
• By Neena Brizmohun

The government wants to raise the statutory scheme payment rate for newer branded medicines from 15.5% to 32.2%, after sales data for Q2 and Q3 2024 showed “higher than expected newer medicines sales growth.”

Man gives a British sterling money bag.
The ABPI said that payment rates under the statutory and voluntary schemes were rocketing (Shutterstock)

More from Government Payers

More from Geography